Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
New, James S.
and
Takaki, Katherine S.
1988.
Vol. 23,
Issue. ,
p.
1.
Lepola, U.
Koskinen, T.
Rimón, R.
Salo, H.
and
Gordin, A.
1989.
Sulpiride and perphenazine in schizophrenia.
Acta Psychiatrica Scandinavica,
Vol. 80,
Issue. 1,
p.
92.
King, D.J.
Devaney, N.
Cooper, S.J.
Blomqvist, M.
and
Mitchell, M.J.
1990.
Pharmacokinetics and antipsychotic effect of remoxipride in chronic schizophrenic patients.
Journal of Psychopharmacology,
Vol. 4,
Issue. 2,
p.
83.
Soni, S. D.
Mallik, A.
and
Schiff, A. A.
1990.
Sulpiride in negative schizophrenia: A placebo‐controlled double‐blind assessment.
Human Psychopharmacology: Clinical and Experimental,
Vol. 5,
Issue. 3,
p.
233.
Martinot, JL
Paillère-Martinot, ML
Loc'h, C
Péron Magnan, P
Mazoyer, B
Lecrubier, Y
Hardy, P
Beaufils, B
Allilaire, JF
Mazière, B
Slama, MF
and
Syrota, A
1990.
Central D2receptor blockade and antipsychotic effects of neuroleptics. Preliminary study with positron emission tomography.
Psychiatry and Psychobiology,
Vol. 5,
Issue. 4,
p.
231.
Silverstone, Trevor
1990.
Clinically relevant differences between antipsychotic compounds.
Acta Psychiatrica Scandinavica,
Vol. 82,
Issue. S358,
p.
88.
de Beaurepaire, R.
1991.
Brain Dopaminergic Systems: Imaging with Positron Tomography.
p.
147.
Dollfus, Sonia
Petit, Michel
Menard, Jean F.
and
Lesieur, Philippe
1992.
Amisulpride versus bromocriptine in infantile autism: A controlled crossover comparative study of two drugs with opposite effects on dopaminergic function.
Journal of Autism and Developmental Disorders,
Vol. 22,
Issue. 1,
p.
47.
Tegeler, J.
1993.
Therapieresistenz unter Neuroleptikabehandlung.
p.
115.
Michels, Robert
and
Marzuk, Peter M.
1993.
Progress in Psychiatry.
New England Journal of Medicine,
Vol. 329,
Issue. 8,
p.
552.
Fleischhacker, W.W.
and
Whitworth, A.B.
1993.
Classical antipsychotics in the treatment of negative symptoms.
European Neuropsychopharmacology,
Vol. 3,
Issue. 3,
p.
210.
Meltzer, Herbert Y.
Lee, Myung A.
and
Ranjan, Rakesh
1994.
Recent advances in the pharmacotherapy of schxzophrenia.
Acta Psychiatrica Scandinavica,
Vol. 90,
Issue. s384,
p.
95.
Laux, G.
1994.
Fortschritte in der Diagnostik und Therapie schizophrener Minussymptomatik.
p.
207.
Caley, Charles F.
and
Weber, Stanley S.
1995.
Sulpiride: an Antipsychotic with Selective Dopaminergic Antagonist Properties.
Annals of Pharmacotherapy,
Vol. 29,
Issue. 2,
p.
152.
Dollfus, S.
and
Petit, M.
1995.
Análisis de componentes principales de la PANSS y la SANS-SAPS en esquizofrenia: su estabilidad en una fase aguda.
European psychiatry (Ed. Española),
Vol. 2,
Issue. 4,
p.
219.
Mucci, A.
Nolfe, G.
and
Maj, M.
1995.
Levosulpiride: a review of its clinical use in psychiatry.
Pharmacological Research,
Vol. 31,
Issue. 2,
p.
95.
Storey, V.J.
Middlemiss, D.N.
and
Reavill, C.
1995.
Effect of haloperidol and (−)-sulpiride on dopamine agonist-induced hypoactivity.
Neuropharmacology,
Vol. 34,
Issue. 4,
p.
449.
Dollfus, S
and
Petit, M
1995.
Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase.
European Psychiatry,
Vol. 10,
Issue. 2,
p.
97.
Ronchi, Diana De
Ruggeri, Mirella
Belelli, Gabriella
and
Volterra, Vittorio
1996.
Levosulpiride versus pimozide in negative symptoms of schizophrenia.
Current Therapeutic Research,
Vol. 57,
Issue. 10,
p.
797.
Pantelis, Christos
and
Barnes, Thomas R.E.
1996.
Drug Strategies and Treatment-Resistant Schizophrenia.
Australian & New Zealand Journal of Psychiatry,
Vol. 30,
Issue. 1,
p.
20.
eLetters
No eLetters have been published for this article.